Clinically-relevant proteomic and metabolomic signatures with effective neuroprotective treatment of the Tg4344AD rat model of Alzheimer’s disease

by Cyrus Huneycutt | Jan 5, 2026 | 0 comments

Submit a Comment Cancel reply

You must be logged in to post a comment.